The European Monitoring Center for Drugs and Drug Addiction (EMCDDA) again registered 41 new drugs last year. This expanding range of psychoactive substances on the market poses particular challenges for policy and public health, the observatory warns in its annual report today.
ttn-3
EU concerned about more complex drug market: 41 new drugs registered in 2022
